Evidence map›Paper›PMID 35037981›Full record

ArticleEuropean journal of clinical pharmacology2022

European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology.

Andrej Belančić, Carla Sans-Pola, Emilie Jouanjus, Pau Alcubilla, Ana Lucía Arellano, Miodrag Žunić, Rita Nogueiras-Álvarez, Rossana Roncato, Joaquín Sáez-Peñataro, EACPT Young Clinical Pharmacologists Working Group

Abstract read
In one paragraph

Article in European journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andrej BelančićDepartment of Clinical Pharmacology, Clinical Hospital Centre Rijeka, Krešimirova 42, 51000, Rijeka, Croatia. a.belancic93@gmail.com.ORCID http://orcid.org/0000-0001-7848-6600
Carla Sans-PolaDepartment of Clinical Pharmacology, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
Emilie JouanjusAddictovigilance Center, Department of Medical Pharmacology, Toulouse University Hospital, Toulouse, France.
Pau AlcubillaDepartment of Clinical Pharmacology, Hospital Clinic of Barcelona, Barcelona, Spain.
Ana Lucía ArellanoDepartment of Clinical Pharmacology, Hospital Clinic of Barcelona, Barcelona, Spain.
Miodrag ŽunićDepartment of Anesthesiology, Intensive Care and Pain Management, University Medical Center Maribor, Maribor, Slovenia.
Rita Nogueiras-ÁlvarezDepartment of Clinical Pharmacology, Badajoz University Hospital, Badajoz, Extremadura, Spain.
Rossana RoncatoExperimental and Clinical Pharmacology Unit, Centro Di Riferimento Oncologico Di Aviano (CRO) IRCCS, Aviano, Italy.
Joaquín Sáez-PeñataroDepartment of Clinical Pharmacology, Hospital Clinic of Barcelona, Barcelona, Spain.
EACPT Young Clinical Pharmacologists Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Association for Clinical Pharmacology and Therapeutics (EACPT) is a leading society in Europe serving the European and global Clinical Pharmacology and Therapeutics community. Its specific aims include promotion of the utilisation and divulgation of the utility of clinical pharmacology services in health care delivery. EACPT currently has four active working groups (WGs): Education, Regulatory affairs, Clinical research and Young Clinical Pharmacologists (YCP WG). EACPT YCP WG was established in 2015 with the idea of improving education, research, training and networking/mobility opportunities for YCPs across Europe and globe. The main objective of the present manuscript is to provide detailed information on general characteristics, structure, chronogram, objectives, accomplishments and current/future focus areas of the EACPT YCP WG. Consequently, we tend to notably enhance EACPT YCP WG's visibility, increase the number of its members and mobility/networking options and to expand areas of activity even more. Moreover, by this we can also make clinical pharmacology more attractive to early career fellows and colleagues and empower its position alongside other medical specialties.

Indexed as

PharmacologyPharmacology, ClinicalDelivery of Health CareEuropeHumansClinical pharmacologyEducationMedical specialtyMobilityResearchSocial networking

Identifiers

PMID35037981
PMCPMC8761867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.